Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. | 4,316,618 | reported | 12 May 2025 | tx 11+912,264 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2025 | CONVERSION | Apimeds Pharmaceuticals US, Inc. | 44,041 | 2.60 USD | |
| 12 May 2025 | CONVERSION | Apimeds Pharmaceuticals US, Inc. | 71,090 | 2.60 USD | |
| 12 May 2025 | CONVERSION | Apimeds Pharmaceuticals US, Inc. | 182,002 | 2.60 USD | |
| 12 May 2025 | PURCHASE | Apimeds Pharmaceuticals US, Inc. | 500,000 | 4.00 USD | |
| 12 May 2025 | CONVERSION | Apimeds Pharmaceuticals US, Inc. | — | 0.00 USD | deriv |
| 12 May 2025 | CONVERSION | Apimeds Pharmaceuticals US, Inc. | — | 0.00 USD | deriv |
| 12 May 2025 | CONVERSION | Apimeds Pharmaceuticals US, Inc. | — | 0.00 USD | deriv |